Patient's dramatic response and resistance to cancer drug traced to unsuspected mutations
The DNA of a woman whose lethal thyroid cancer unexpectedly "melted away" for 18 months has revealed new mechanisms of cancer response and resistance to the drug everolimus, said researchers from Dana-Farber Cancer Institute ...
Oct 8, 2014
0
0